High materiality7/10
Astrana Health price target raised to $55 from $47 at Truist
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Truist Financial raises ASTH's price target to $55 from $47; current price is $37.47.
- Target: $55 (from $47)
- Current price: $37.47
- Analyst: Truist Financial
Key facts
- 01
Target: $55
- 02
Posted price: $37.47
- 03
Analyst firm: Truist Financial
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.